Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report.

Urquhart, Siri A; Chedid, Victor G; Kane, Sunanda V

Urquhart, Siri A; Chedid, Victor G; Kane, Sunanda V.

Afiliação

Urquhart SA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Chedid VG; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Kane SV; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Inflamm Bowel Dis ; 2024 Jul 05.

Article em En | MEDLINE | ID: mdl-38970379

Upadacitinib, a selective JAK-1 inhibitor, was used as rescue therapy for ulcerative colitis in the setting of pregnancy following use of mesalamine, vedolizumab, infliximab, and corticosteroids. This resulted in an uncomplicated live full birth without need for surgical intervention.

Palavras-chave

inflammatory bowel disease; pregnancy; ulcerative colitis; upadacitinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links